RxDoctor Payments Data

John Howell, PA

Physician Assistant · Murfreesboro, ARNPI 1619129616

Payments from drug & device makers

$442in general payments, 2019–2025

Across 25 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$117
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$81
  • Otsuka America Pharmaceutical, Inc.$49
  • AbbVie$48
  • Harmony Biosciences LLC$33
  • Silk Road Medical, Inc.$24
  • plus $91 from 5 others

What the payments were for

  • Food & beverage$442100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$442 in reported general payments places this provider in the 50th percentile of 451 physician assistant providers in Arkansas.

See all physician assistant providers in Arkansas

Medicare billing

Part B allowed, 2024
$14,914
Medicare patients
237
Services billed
1,053

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide109$117,952
Trelegy ElliptaFluticasone/Umeclidin/Vilanter127$86,305
EliquisApixaban107$71,460
JanuviaSitagliptin Phosphate67$61,380
FarxigaDapagliflozin Propanediol85$56,701
OzempicSemaglutide51$56,598
JardianceEmpagliflozin48$41,660
TrulicityDulaglutide40$40,382
ProvigilModafinil12$27,032
XareltoRivaroxaban26$15,466
BrilintaTicagrelor29$14,659
MyrbetriqMirabegron22$11,075
LinzessLinaclotide20$10,863
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$9,392
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$8,924

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$117$158,334149 claims
AstraZenecaFarxiga, Brilinta, Breztri Aerosphere, Symbicort$22$89,194154 claims
MerckJanuvia$21$61,38067 claims
Novo NordiskOzempic$16$56,59851 claims
AbbVieLinzess$48$10,86320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 451 physician assistant providers in Arkansas.

Other physician assistant in Murfreesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →